Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Leverich, G. S. Articles by Post, R. M. Search for Related Content PubMed Citation Articles by Leverich, G. S. Articles by Post, R. M. Bipolar Disorder Antidepressants

Risk of Switch in Mood Polarity to Hypomania or Mania in Patients With Bipolar Depression During Acute and Continuation Trials of Venlafaxine, Sertraline, and Bupropion as Adjuncts to Mood Stabilizers

OBJECTIVE: The authors examined the comparative risks of switches in mood polarity into hypomania or mania during acute and continuation trials of adjunctive antidepressant treatment of bipolar depression. METHOD: One hundred fifty-nine patients with bipolar I disorder or bipolar II disorder participated in a total of 228 acute (10-week) randomized trials of bupropion, sertraline, or venlafaxine as an adjunct to a mood stabilizer. Patients in 87 of these trials entered continuation treatment for up to 1 year. Antidepressant response and the occurrence of subthreshold brief hypomania (emergence of brief hypomania [at least 1 but <7 days] or recurrent brief hypomania) and threshold switches (emergence of full-duration hypomania [7 days] or mania) were blindly assessed by using clinician-rated daily reports of mood-associated dysfunction on the National Institute of Mental Health Life Chart Method. RESULTS: Threshold switches into full-duration hypomania and mania occurred in 11.4% and 7.9%, respectively, of the acute treatment trials and in 21.8% and 14.9%, respectively, of the continuation trials. The rate of threshold switches was higher in the 169 trials in patients with bipolar I disorder (30.8%) than the 59 trials in patients with bipolar II disorder (18.6%). The ratio of threshold switches to subthreshold brief hypomanias was higher in both the acute (ratio=3.60) and continuation trials (ratio=3.75) of venlafaxine than in the acute and continuation trials of bupropion (ratios=0.85 and 1.17, respectively) and sertraline (ratios=1.67 and 1.66, respectively). In only 37 (16.2%) of the original 228 acute antidepressant trials, or in only 23.3% of the patients, was there a sustained antidepressant response in the continuation phase in the absence of a threshold switch. CONCLUSIONS: Adjunctive treatment with antidepressants in bipolar depression was associated with substantial risks of threshold switches to full-duration hypomania or mania in both acute and long-term continuation treatment. Of the three antidepressants included in the study, venlafaxine was associated with the highest relative risk of such switching and bupropion with the lowest risk.

This article has been cited by other articles:

				D. Smith, S. Ghaemi, and N Craddock The broad clinical spectrum of bipolar disorder: implications for research and practice J Psychopharmacol, June 1, 2008; 22(4): 397 - 400. [PDF]

				R.H. Belmaker Treatment of Bipolar Depression N. Engl. J. Med., April 26, 2007; 356(17): 1771 - 1773. [Full Text] [PDF]

				G. S. Sachs, A. A. Nierenberg, J. R. Calabrese, L. B. Marangell, S. R. Wisniewski, L. Gyulai, E. S. Friedman, C. L. Bowden, M. D. Fossey, M. J. Ostacher, et al. Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression N. Engl. J. Med., April 26, 2007; 356(17): 1711 - 1722. [Abstract] [Full Text] [PDF]

				Bibliography BIPOLAR DISORDER Focus, January 1, 2007; 5(1): 40 - 43. [Full Text] [PDF]

				G. S. Leverich, L. L. Altshuler, M. A. Frye, T. Suppes, S. L. McElroy, P. E. Keck Jr., R. W. Kupka, K. D. Denicoff, W. A. Nolen, H. Grunze, et al. Risk of Switch in Mood Polarity to Hypomania or Mania in Patients With Bipolar Depression During Acute and Continuation Trials of Venlafaxine, Sertraline, and Bupropion as Adjuncts to Mood Stabilizers Focus, January 1, 2007; 5(1): 98 - 106. [Abstract] [Full Text] [PDF]

				L. L. Altshuler, T. Suppes, D. O. Black, W. A. Nolen, G. Leverich, P. E. Keck Jr., M. A. Frye, R. Kupka, S. L. McElroy, H. Grunze, et al. Lower Switch Rate in Depressed Patients With Bipolar II Than Bipolar I Disorder Treated Adjunctively With Second-Generation Antidepressants Focus, January 1, 2007; 5(1): 107 - 110. [Abstract] [Full Text] [PDF]

				J. A. MATTES Less Mood Switching With Venlafaxine? Am J Psychiatry, September 1, 2006; 163(9): 1642 - 1642. [Full Text] [PDF]

				R. M. Post, L. L. Altshuler, G. S. Leverich, M. A. Frye, W. A. Nolen, R. W. Kupka, T. Suppes, S. McElroy, P. E. Keck, K. D. Denicoff, et al. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline The British Journal of Psychiatry, August 1, 2006; 189(2): 124 - 131. [Abstract] [Full Text] [PDF]

				Polarity Switches in Bipolar Patients Taking Mood Stabilizers and Antidepressants Journal Watch Psychiatry, March 22, 2006; 2006(322): 2 - 2. [Full Text]

				L. L. Altshuler, T. Suppes, D. O. Black, W. A. Nolen, G. Leverich, P. E. Keck Jr., M. A. Frye, R. Kupka, S. L. McElroy, H. Grunze, et al. Lower Switch Rate in Depressed Patients With Bipolar II Than Bipolar I Disorder Treated Adjunctively With Second-Generation Antidepressants Am J Psychiatry, February 1, 2006; 163(2): 313 - 315. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us